Lv12
48 积分 2023-05-05 加入
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
4小时前
待确认
Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins
13天前
已完结
Quantitative Membrane Proteomics for Discovery of Actionable Drug Targets at the Surface of RAS-Driven Human Cancer Cells
1个月前
已完结
From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer
2个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
3个月前
已完结
PF-08046032: A novel, investigational CD25-directed antibody-drug conjugate optimized for selective depletion of regulatory T cells in advanced malignant tumors
4个月前
已完结
Exploring the next generation of antibody–drug conjugates
5个月前
已完结
Discovery of a fully human antibody to the proximal membrane terminus of MUC1 based on a B-cell high-throughput screening technique
5个月前
已完结
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies
8个月前
已完结
皖公网安备34019202002308
